Published in Hepatology on December 22, 1981
Alcohol induced liver disease. J Clin Pathol (1984) 1.63
The role of cytokines in UbD promoter regulation and Mallory-Denk body-like aggresomes. Exp Mol Pathol (2010) 1.18
Alcoholic and non-alcoholic steatohepatitis. Exp Mol Pathol (2014) 0.89
The inflammasome in alcoholic hepatitis: Its relationship with Mallory-Denk body formation. Exp Mol Pathol (2014) 0.87
Is the expression of gamma-glutamyl transpeptidase messenger RNA an indicator of biological behavior in recurrent hepatocellular carcinoma? World J Gastroenterol (2003) 0.81
Levels of metacaspase1 and chaperones related to protein quality control in alcoholic and nonalcoholic steatohepatitis. Exp Mol Pathol (2014) 0.81
The immunoproteasome in steatohepatitis: its role in Mallory-Denk body formation. Exp Mol Pathol (2011) 0.81
Disorganisation of intermediate filament structure in alcoholic and other liver diseases. Gut (1986) 0.79
Expression of tissue polypeptide antigen (TPA) in fetal and adult liver: changes in liver disease. J Clin Pathol (1987) 0.78
Interaction of alcohol with other drugs and nutrients. Implication for the therapy of alcoholic liver disease. Drugs (1990) 0.77
Alcoholic liver disease: a synopsis of the Charles Lieber's Memorial Symposia 2009-2012. Alcohol Alcohol (2014) 0.76
Immunohistochemical and ultrastructural analyses of cytoplasmic blood plasma inclusions of rat hepatocytes. J Toxicol Pathol (2012) 0.75
The mechanisms of Mallory-Denk body formation are similar to the formation of aggresomes in Alzheimer's disease and other neurodegenerative disorders. Exp Mol Pathol (2016) 0.75
Over expression of proteins that alter the intracellular signaling pathways in the cytoplasm of the liver cells forming Mallory-Denk bodies. Exp Mol Pathol (2017) 0.75
Beef fat prevents alcoholic liver disease in the rat. Alcohol Clin Exp Res (1989) 2.18
Experimental models of hepatic fibrosis: a review. Semin Liver Dis (1990) 1.81
Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. The VA Cooperative Study Group (No. 119) Hepatology (1991) 1.78
Cell-mediated hepatic injury in alcoholic liver disease. Veterans Affairs Cooperative Study Group 275. Gastroenterology (1993) 1.52
Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. Am J Gastroenterol (1991) 1.51
Reduced virulence of HWP1-deficient mutants of Candida albicans and their interactions with host cells. Infect Immun (2000) 1.48
Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology (1986) 1.48
Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol. Hepatology (1996) 1.41
Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology. Hepatology (1997) 1.37
Clinically silent primary adrenal lymphoma: a case report and review of the literature. Am J Hematol (1998) 1.36
Severe and progressive steatosis and focal necrosis in rat liver induced by continuous intragastric infusion of ethanol and low fat diet. Hepatology (1985) 1.33
Mallory body induction in drug-primed mouse liver. Hepatology (1996) 1.30
Insights into the pathogenesis of alcoholic liver necrosis and fibrosis: status report. Hepatology (1990) 1.28
Cyclical pattern of blood alcohol levels during continuous intragastric ethanol infusion in rats. Alcohol Clin Exp Res (1985) 1.28
Ultrastructural localization of actin-like filaments in rat hepatocytes. Gastroenterology (1975) 1.24
Dietary factors and alcoholic cirrhosis. Alcohol Clin Exp Res (1986) 1.24
Models of alcoholic liver disease in rodents: a critical evaluation. Alcohol Clin Exp Res (2001) 1.23
Reduced susceptibility of mice overexpressing transforming growth factor alpha to dextran sodium sulphate induced colitis. Gut (1998) 1.21
Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole. Proc Soc Exp Biol Med (2000) 1.21
Iron primes hepatic macrophages for NF-kappaB activation in alcoholic liver injury. Am J Physiol (1999) 1.20
Mechanism of the alcohol cyclic pattern: role of the hypothalamic-pituitary-thyroid axis. Am J Physiol Gastrointest Liver Physiol (2000) 1.20
Long-term cannulation model for blood sampling and intragastric infusion in the rat. Am J Physiol (1984) 1.15
The effect of ethanol-induced cytochrome p4502E1 on the inhibition of proteasome activity by alcohol. Biochem Biophys Res Commun (2000) 1.13
Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes. Lab Invest (1988) 1.12
A method of isolation of Mallory bodies in a purified fraction. Lab Invest (1972) 1.11
TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma. Lab Invest (2001) 1.10
The role of the Ito cell in perivenular and intralobular fibrosis in alcoholic hepatitis. Arch Pathol Lab Med (1983) 1.09
Fish oil, alcohol, and liver pathology: role of cytochrome P450 2E1. Proc Soc Exp Biol Med (1994) 1.08
Role of cytochrome P4502E1 in alcoholic liver disease pathogenesis. Alcohol (1994) 1.08
Dietary linoleic acid is required for development of experimentally induced alcoholic liver injury. Life Sci (1989) 1.07
Effects of chronic ethanol administration on rat liver proteasome activities: relationship with oxidative stress. Hepatology (1999) 1.07
Bile duct changes in alcoholic liver disease. The Veterans Administration Cooperative Study Group. Liver (1993) 1.07
Expression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease. Life Sci (1995) 1.06
Ethanol-induced hepatic fibrosis in the rat: role of the amount of dietary fat. Alcohol Clin Exp Res (1986) 1.06
Nesidioblastosis coexisting with islet cell tumor and intraductal papillary mucinous hyperplasia. Arch Pathol Lab Med (2001) 1.06
Connections of intermediate filaments with the nuclear lamina and the cell periphery. Biol Cell (1987) 1.05
Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibitors. Hepatology (1995) 1.05
The cyclic pattern of blood alcohol levels during continuous ethanol feeding in rats: the effect of feeding S-adenosylmethionine. Exp Mol Pathol (2010) 1.05
Pancreatic hamartoma with Langerhans cell histiocytosis in a draining lymph node. Histopathology (1998) 1.04
Aggresome formation in liver cells in response to different toxic mechanisms: role of the ubiquitin-proteasome pathway and the frameshift mutant of ubiquitin. Exp Mol Pathol (2001) 1.03
Potentiation of ethanol-induced pancreatic injury by dietary fat. Induction of chronic pancreatitis by alcohol in rats. Am J Pathol (1988) 1.03
Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas. Oncogene (2007) 1.02
Mallory-Denk bodies form when EZH2/H3K27me3 fails to methylate DNA in the nuclei of human and mice liver cells. Exp Mol Pathol (2012) 1.01
The ultrastructure of Mallory body filaments. Lab Invest (1973) 1.01
Dexamethasone enhances mallory body formation in drug-primed mouse liver. Exp Mol Pathol (2000) 1.00
Cellular origin of gastrointestinal stromal tumors: a study of 27 cases. Arch Pathol Lab Med (2000) 0.98
Primitive neuroectodermal tumor of the pulmonary hilum in an adult. Ann Thorac Surg (2001) 0.98
Gastric adenocarcinoma with a yolk sac component: a case report and review of the literature. J Clin Gastroenterol (2000) 0.98
Mallory body formation runs parallel to gamma-glutamyl transferase induction in hepatocytes of griseofulvin-fed mice. Hepatology (1983) 0.97
Centrilobular liver necrosis induced by hypoxia in chronic ethanol-fed rats. Hepatology (1984) 0.95
Serum alanine aminotransferase to aspartate aminotransferase ratio and degree of fatty liver in morbidly obese patients. Enzyme (1986) 0.94
Cytokeratin intermediate filaments of rat hepatocytes: different cytoskeletal domains and their three-dimensional structure. Hepatology (1988) 0.94
Mallory bodies: isolation of hepatocellular hyalin and electrophoretic resolution of polypeptide components. Lab Invest (1978) 0.93
Inhibition of PPAR alpha/RXR alpha-mediated direct hyperplasia pathways during griseofulvin-induced hepatocarcinogenesis. J Cell Biochem (1998) 0.92
The Mallory body as an aggresome: in vitro studies. Exp Mol Pathol (2002) 0.92
Hydroxyethyl radicals in ethanol hepatotoxicity. Front Biosci (1999) 0.92
Hepatic adenine nucleotide metabolism measured in vivo in rats fed ethanol and a high fat-low protein diet. Hepatology (1988) 0.92
Relationship between pork consumption and cirrhosis. Lancet (1985) 0.92
Heat shock proteins are present in mallory bodies (cytokeratin aggresomes) in human liver biopsy specimens. Exp Mol Pathol (2003) 0.91
Autoantibodies against cytochromes P-4502E1 and P-4503A in alcoholics. Mol Pharmacol (1999) 0.91
Experimental carotid stenosis due to fibrous intimal hyperplasia. Surg Gynecol Obstet (1981) 0.89
Peptidase activities of the multicatalytic protease in rat liver after voluntary and intragastric ethanol administration. Hepatology (1998) 0.89
Betaine feeding prevents the blood alcohol cycle in rats fed alcohol continuously for 1 month using the rat intragastric tube feeding model. Exp Mol Pathol (2011) 0.89
Peroxidase-antiperoxidase complex. Binding by Mallory bodies in unfixed tissue. Arch Pathol Lab Med (1976) 0.89
Liver necrosis induced by thyroid hormone administration in rats fed ethanol. Exp Mol Pathol (2001) 0.89
Uncoupling of oxidative phosphorylation prevents the urinary alcohol level cycling caused by feeding ethanol continuously at a constant rate. Exp Mol Pathol (2005) 0.88
Nature, pathogenesis and significance of the Mallory body. Semin Liver Dis (1981) 0.88
Mallory body formation by ethanol feeding in drug-primed mice. Hepatology (1998) 0.88
Mallory bodies. Horseradish peroxidase: specific cytochemical and biochemical marker for alcoholic hyalin. Lab Invest (1979) 0.88
Modifications in cytokeratin and actin in cultured liver cells derived from griseofulvin-fed mice. Lab Invest (1995) 0.87
Changes in IL12A methylation pattern in livers from mice fed DDC. Exp Mol Pathol (2012) 0.87
Alcoholic liver disease. Med Clin North Am (1984) 0.87
The mechanism of cytokeratin aggresome formation: the role of mutant ubiquitin (UBB+1). Exp Mol Pathol (2003) 0.86
Effect of the type of beverage and meat consumed by alcoholics with alcoholic liver disease. Alcohol Clin Exp Res (1998) 0.86
Early morphologic changes in serum-induced renal papillary necrosis. Light and electron microscopic studies. Lab Invest (1967) 0.86
Effect of chronic ethanol ingestion on liver enzyme changes induced by thiamine, riboflavin, pyridoxine, or choline deficiency. J Nutr (1966) 0.86
Mechanisms of mallory body formation induced by okadaic acid in drug-primed mice. Exp Mol Pathol (1998) 0.86
Comparative electrophoretic study of Mallory body and intermediate filament protein. J Med (1978) 0.86
Mallory bodies compared with microfilament hyperplasia. Arch Pathol Lab Med (1977) 0.85
Some effects of chronic ethanol feeding on vitamin B 6 deficiency in the rat. Lab Invest (1967) 0.85
Present understanding of the development of Mallory's body. Arch Pathol Lab Med (1983) 0.85
Effect of acute and chronic ethanol ingestion on rat liver ATP. Proc Soc Exp Biol Med (1966) 0.84
Fascioliasis causing obstructive jaundice. Gastrointest Endosc (1998) 0.84
Role of cytoskeleton in canalicular contraction in cultured differentiated hepatocytes. Am J Pathol (1990) 0.84
Changes in the cytokeratin intermediate filament cytoskeleton associated with Mallory body formation in mouse and human liver. Hepatology (1988) 0.84
Distinctive infrared spectral features in liver tumor tissues of mice: evidence of structural modifications at the molecular level. Exp Mol Pathol (1991) 0.84
Molecular structural changes in Mallory body proteins in human and mouse livers: an infrared spectroscopy study. Exp Mol Pathol (1993) 0.84
Selective accumulation of IF proteins at a focal juxtanuclear site in COS-1 cells transfected with mouse keratin 18 cDNA. Exp Cell Res (1990) 0.83
CYP-2E1 inhibitors partially ameliorate the changes in hepatic fatty acid composition induced in rats by chronic administration of ethanol and a high fat diet. J Nutr (1995) 0.83
Testosterone replacement ameliorates nonalcoholic fatty liver disease in castrated male rats. Endocrinology (2013) 0.83
Alteration in molecular structure of cytoskeleton proteins in griseofulvin-treated mouse liver: a pressure tuning infrared spectroscopy study. Exp Mol Pathol (1991) 0.83
The connection between the nuclei of binucleated hepatocytes: an ultrastructural study. J Submicrosc Cytol Pathol (1994) 0.83
Pathologic changes in the cytokeratin pericanalicular sheath in experimental cholestasis and alcoholic fatty liver. Lab Invest (1988) 0.82
Relationship of Mallory bodies to intermediate filaments in hepatocytes. A scanning electron microscopy study. Lab Invest (1985) 0.82
Microtubules are required for cytokeratin aggresome (Mallory body) formation in hepatocytes: an in vitro study. Exp Mol Pathol (2003) 0.82
Effect of agents which rearrange the cytoskeleton in vitro on the structure and function of hepatocytic canaliculi. Lab Invest (1989) 0.82
In vivo hepatic energy metabolism during the progression of alcoholic liver disease: a noninvasive 31P nuclear magnetic resonance study in rats. Hepatology (1990) 0.82
Correlations between deviations from expected cirrhosis mortality and serum uric acid and dietary protein intake. J Stud Alcohol (1986) 0.82
Dietary induced glomerulosclerosis in the guinea pig. Arch Pathol (1967) 0.82
"Piecemeal" necrosis: renamed troxis necrosis. Exp Mol Pathol (2001) 0.82